youtube_live
Q3 2026 earnings • in 3 days
See detailschevron_right
STVN:NYSE
Stevanato Group SpA
$19.38
arrow_downward
-4.25%(-0.86) 1D
Oct 30, 4:00:04 PM GMT-4 · USD
search
All symbols
No data
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for STVN...
Open
$20.51
High
$20.80
Low
$19.03
Mkt. cap
5.29B
Avg. vol.
329.77K
Volume
557.66K
Dividend
0.32%
Quarterly dividend
$0.02
Ex-dividend date
Jun 11, 2026
P/E ratio
35.17
52-wk high
$27.00
52-wk low
$12.89
EPS
$0.55
Beta
0.78
Shares outstanding
49.71M
No. of employees
6K
Open
$20.51
High
$20.80
Low
$19.03
Mkt. cap
5.29B
Avg. vol.
329.77K
Volume
557.66K
Dividend
0.32%
Quarterly dividend
$0.02
Ex-dividend date
Jun 11, 2026
P/E ratio
35.17
52-wk high
$27.00
52-wk low
$12.89
EPS
$0.55
Beta
0.78
Shares outstanding
49.71M
No. of employees
6K
News stories
From web sources and news partners
TradingView
·
2 hours ago
S&P 500, Nasdaq End Third Straight Week Lower As Investors Move Away From Tech, AI — AMZN, INTC, LLY, RBLX In Focus
The Motley Fool
·
7 hours ago
Bloom Energy Just Joined the S&P 500. Here's What History Says Happens Next.
FOREX.com
·
5 hours ago
Dow Jones Slide Shows What Rate Hike Bets Mean for Stocks
Profile
Stevanato Group is an Italian multinational company headquartered in Piombino Dese, Padua – Italy.
Founded in 1949, it is also active in the glass tube forming technology and inspection systems sector.
The Group is the first worldwide producer of insulin cartridges for diabetes treatment and design and production of machinery for glass tubing converting. Wikipedia
About Stevanato Group SpA
Analyst ratings
Based on 7 analysts giving stock ratings to STVN in the past 3 months
Buy
Buy
4
Hold
3
Sell
0
12-month forecast
Based on 7 Wall Street analysts offering 12 month price targets for STVN in the last 3 months.
Highest
Current $19.38
$26.00 (+34.16%)
Average
$23.20 (+19.71%)
Lowest
$20.00 (+3.20%)
Analyst | Recommendation | Action | Price target | Projected | Date |
|---|---|---|---|---|---|
Chad Wiatrowski TD Cowen | Buy | Reiterated | $25.00 | +29% | 10/14/2026 |
Justin Bowers Deutsche Bank | Hold | Initiated | $22.00 | +13.5% | 10/07/2026 |
Kallum Titchmarsh Morgan Stanley | Hold | Reiterated | $20.00 | +3.2% | 10/05/2026 |
Unknown Analyst Citi | Buy | Maintained | $26.00 | +34.2% | 10/01/2026 |
Albert Hu Citi | Buy | Maintained | $26.00 | +34.2% | 10/01/2026 |
Unknown Analyst UBS | Hold | Initiated | $23.00 | +18.7% | 09/08/2026 |
Doug Schenkel UBS | Hold | Maintained | $23.00 | +18.7% | 09/09/2026 |
Michael Ryskin Bank of America Securities | Buy | Maintained | - | - | 08/05/2026 |
Matt Larew William Blair | Buy | Maintained | - | - | 08/05/2026 |
Brendan Smith TD Cowen | Buy | Reiterated | $25.00 | +29% | 07/15/2026 |
Patrick B Donnelly Citi | Buy | Maintained | $26.00 | +34.2% | 07/08/2026 |
Michael Polark Wolfe Research | Buy | Initiated | $21.00 | +8.4% | 06/01/2026 |
Paul Knight KeyBanc | Buy | Reiterated | $32.00 | +65.1% | 03/05/2026 |
David Windley Jefferies | Hold | Maintained | $17.50 | -9.7% | 02/10/2026 |
Next call in 3 days
Tue, Nov 3, 3:30 PM
Fiscal period
Q3 2026
- Normalized EPS / Est. (EUR)
- GAAP EPS / Est. (EUR)
- / €0.18
Revenue / Est. (EUR)
- / 320.67M
Fiscal Q3 2026 earnings call
youtube_liveWaiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
- Quarterly
- Annual
All values in EUR | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
Revenue | 303.17M | 346.48M | 273.57M | 302.00M |
Cost of goods sold | 214.37M | 237.76M | 198.10M | 214.69M |
Cost of revenue | 214.37M | 237.76M | 198.10M | 214.69M |
Research and development expenses | 7.65M | 5.81M | 5.84M | 6.21M |
Total research and development expenses | - | - | - | - |
Selling, general, and admin expenses | 30.32M | 34.05M | 32.09M | 31.53M |
Operating expense | 35.25M | 36.39M | 36.52M | 35.31M |
Total operating expenses | 249.61M | 274.15M | 234.62M | 250.00M |
Operating income | 53.55M | 72.33M | 38.96M | 52.00M |
Other non operating income | -1.66M | -1.19M | -1.56M | 9.00K |
EBT including unusual items | 49.13M | 65.76M | 39.24M | 38.12M |
EBT excluding unusual items | 50.03M | 68.08M | 39.54M | 51.15M |
Income tax expense | 13.06M | 18.21M | 11.21M | 15.16M |
Effective tax rate | 26.59% | 27.69% | 28.57% | 39.78% |
Other operating expenses | -2.72M | -3.47M | -1.41M | -2.44M |
Net income | 36.06M | 47.56M | 28.03M | 22.96M |
Net profit margin | 11.90% | 13.72% | 10.25% | 7.60% |
Earnings per share | - | - | - | - |
Interest and investment income | 390.00K | 216.00K | 281.00K | 338.00K |
Interest expense | -1.77M | -1.60M | -1.16M | -1.28M |
Net interest expenses | -1.38M | -1.38M | -879.00K | -947.00K |
Depreciation and amortization charges | - | - | - | - |
EBITDA | 73.34M | 93.69M | 61.50M | 74.22M |
Gain or loss from assets sale | -1.00K | 8.00K | 89.00K | 10.90M |
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider | Position | Type | Date | Shares | Amount |
|---|---|---|---|---|---|
Page 1
Upcoming events